Characterization of the Proinflammatory Cytokine Profile during Acute SARS-CoV-2 Infection in People with Human Immunodeficiency Virus
Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in p...
Saved in:
Published in | Japanese Journal of Infectious Diseases Vol. 77; no. 6; pp. 301 - 310 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
National Institute of Infectious Diseases
29.11.2024
Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in people with HIV (PWH) with effective combination antiretroviral therapy. There were no significant differences in any of the measured cytokines between severity levels of coronavirus disease 2019 (COVID-19) in PWH, while most were significantly higher in HIV-uninfected individuals with severe COVID-19, suggesting that excess cytokines release by hyperinflammatory responses do not occur in individuals with severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, particularly between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady-state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that they were in an enhanced inflammatory state. The absence of several inter-cytokine correlations was observed in in vitro lipopolysaccharide stimulus-driven cytokine production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially because of the underlying inflammatory state and/or impairment of innate immune cells. |
---|---|
AbstractList | Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in people with HIV (PWH) with effective combination antiretroviral therapy. There were no significant differences in any of the measured cytokines between severity levels of coronavirus disease 2019 (COVID-19) in PWH, while most were significantly higher in HIV-uninfected individuals with severe COVID-19, suggesting that excess cytokines release by hyperinflammatory responses do not occur in individuals with severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, particularly between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady-state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that they were in an enhanced inflammatory state. The absence of several inter-cytokine correlations was observed in in vitro lipopolysaccharide stimulus-driven cytokine production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially because of the underlying inflammatory state and/or impairment of innate immune cells.Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in people with HIV (PWH) with effective combination antiretroviral therapy. There were no significant differences in any of the measured cytokines between severity levels of coronavirus disease 2019 (COVID-19) in PWH, while most were significantly higher in HIV-uninfected individuals with severe COVID-19, suggesting that excess cytokines release by hyperinflammatory responses do not occur in individuals with severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, particularly between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady-state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that they were in an enhanced inflammatory state. The absence of several inter-cytokine correlations was observed in in vitro lipopolysaccharide stimulus-driven cytokine production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially because of the underlying inflammatory state and/or impairment of innate immune cells. Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory syndrome-coronavirus 2 (SARS- CoV-2) infection. Plasma levels of multiple proinflammatory cytokines during acute SARS-CoV-2 infection were measured in people with HIV (PWH) with effective combination antiretroviral therapy. There were no significant differences in any of the measured cytokines between severity levels of coronavirus disease 2019 (COVID-19) in PWH, while most were significantly higher in HIV-uninfected individuals with severe COVID-19, suggesting that excess cytokines release by hyperinflammatory responses do not occur in individuals with severe COVID-19 with HIV infection. The strong associations between the cytokines observed in HIV-uninfected individuals, particularly between IFN-α/TNF-α and other cytokines, were lost in PWH. The steady-state plasma levels of IP-10, ICAM-1, and CD62E were significantly higher in PWH, indicating that they were in an enhanced inflammatory state. The absence of several inter-cytokine correlations was observed in in vitro lipopolysaccharide stimulus-driven cytokine production in PWH. These data suggest that inflammatory responses during SARS-CoV-2 infection in PWH are distinct from those in HIV-uninfected individuals, partially because of the underlying inflammatory state and/or impairment of innate immune cells. |
ArticleNumber | JJID.2024.184 |
Author | Koga, Michiko Suzuki, Tadaki Yotsuyanagi, Hiroshi Nakayama-Hosoya, Kaori Sasaki, Hiroaki Miyata, Nobuyuki Miyazaki, Kazuhito Takahashi, Yoshimasa Runtuwene, Lucky Matano, Tetsuro Kawana-Tachikawa, Ai Dang, Thi Thu Thao Tachikawa, Natsuo Anzurez, Alitzel Yoshimura, Yukihiro |
Author_xml | – sequence: 1 fullname: Anzurez, Alitzel organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 2 fullname: Runtuwene, Lucky organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 3 fullname: Dang, Thi Thu Thao organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 4 fullname: Nakayama-Hosoya, Kaori organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 5 fullname: Koga, Michiko organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan – sequence: 6 fullname: Yoshimura, Yukihiro organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan – sequence: 7 fullname: Sasaki, Hiroaki organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan – sequence: 8 fullname: Miyata, Nobuyuki organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan – sequence: 9 fullname: Miyazaki, Kazuhito organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan – sequence: 10 fullname: Takahashi, Yoshimasa organization: Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Japan – sequence: 11 fullname: Suzuki, Tadaki organization: Department of Pathology, National Institute of Infectious Diseases, Japan – sequence: 12 fullname: Yotsuyanagi, Hiroshi organization: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan – sequence: 13 fullname: Tachikawa, Natsuo organization: Department of Infectious Diseases, Yokohama Municipal Citizens’ Hospital, Japan – sequence: 14 fullname: Matano, Tetsuro organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 15 fullname: Kawana-Tachikawa, Ai organization: AIDS Research Center, National Institute of Infectious Diseases, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38945856$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkstu3CAUhlGVqrm0T1CpQuqmG09tgzFejtw2cRSpURNlizA-ZJjYMAWsyn2APHc9l47UbLoBJL7_HODjHJ1YZwGh91m6KDknnyf3BHZxfd18WeRpThcZp6_QWcY5TXJO2Mm8JpQmjKT0FJ2HsE7TvCiy9A06JbyiBS_YGXquV9JLFcGb3zIaZ7HTOK4A33pnrO7lMMjo_ITrKbonY3cb2vSAu9Eb-4iXaoyA75Y_7pLaPSQ5bqwGtatkLL4Ft5nZXyau8NU4SIubYRit60AbZcCqCT8YP4a36LWWfYB3h_kC3X_7el9fJTffL5t6eZMomhc06QgUUgKkoHXBWKHTllaMAXTZfGPKWwKy5BnQkiqZy6ojFc9UQbpWA7Q5uUCf9mU33v0cIUQxmKCg76UFNwZB0pJmhJSEzOjHF-jajd7OhxMkY6wqcsKqmfpwoMZ2gE5svBmkn8TfB54BsgeUdyF40EckS8VWo9hpFFuNYqtRzBrnVPUipUzc6Ylemv4_2WafXYcoH-HYT_poVA-HTFkKth3-yR4ZNX8KAZb8AbXLwK0 |
CitedBy_id | crossref_primary_10_3390_v17010091 |
Cites_doi | 10.1089/aid.2011.0073 10.1371/journal.ppat.1009674 10.4049/jimmunol.168.7.3660 10.1186/s12981-023-00519-x 10.1111/hiv.13515 10.1093/cid/ciab1008 10.1097/QAD.0000000000003597 10.1097/QAI.0000000000002578 10.1038/s41591-020-1051-9 10.1016/j.coi.2012.05.004 10.1016/j.cytogfr.2020.06.001 10.1038/s41467-021-26137-7 10.3389/fimmu.2022.974767 10.1182/blood-2002-07-2103 10.1189/jlb.0410231 10.1038/nature05115 10.7189/jogh.12.05036 10.1128/JVI.01545-07 10.1093/infdis/jiac343 10.1097/QAD.0000000000003276 10.1182/blood.V96.9.3094.h8003094_3094_3101 10.3389/fimmu.2022.832394 10.3390/v12070711 10.3389/fimmu.2019.02677 10.1097/QAD.0000000000000174 10.1101/2023.07.23.23293053 10.1371/journal.pone.0022982 10.7554/eLife.78374 10.1128/JVI.01153-09 10.18637/jss.v025.i01 10.1097/QAD.0b013e328351f756 10.1186/s12933-023-02097-8 10.1016/S2352-3018(21)00239-3 10.1002/jia2.26104 10.1186/s12879-023-08817-5 |
ContentType | Journal Article |
Copyright | 2024 Authors Copyright Japan Science and Technology Agency 2024 |
Copyright_xml | – notice: 2024 Authors – notice: Copyright Japan Science and Technology Agency 2024 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
DOI | 10.7883/yoken.JJID.2024.184 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1884-2836 |
EndPage | 310 |
ExternalDocumentID | 38945856 10_7883_yoken_JJID_2024_184 article_yoken_77_6_77_JJID_2024_184_article_char_en |
Genre | Journal Article |
GroupedDBID | --- .55 29J 2WC 53G 5GY ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL DIK DU5 E3Z EBS EJD F5P FRP GX1 JSF JSH KQ8 OK1 RJT RNS RZJ TR2 W2D X7M XSB AAYXX CITATION OVT CGR CUY CVF ECM EIF NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
ID | FETCH-LOGICAL-c4254-d3e5aaee0eff5665f0b4966eed183648b3ea781e474ca2a9d3981c53dbfeeb23 |
ISSN | 1344-6304 1884-2836 |
IngestDate | Fri Jul 11 09:33:02 EDT 2025 Mon Jun 30 11:57:58 EDT 2025 Thu Jan 02 22:40:01 EST 2025 Thu Apr 24 22:58:24 EDT 2025 Tue Jul 01 03:55:25 EDT 2025 Thu Dec 05 17:45:04 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | SARS-CoV-2 proinflammatory cytokines innate responses HIV |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4254-d3e5aaee0eff5665f0b4966eed183648b3ea781e474ca2a9d3981c53dbfeeb23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/yoken/77/6/77_JJID.2024.184/_article/-char/en |
PMID | 38945856 |
PQID | 3166952369 |
PQPubID | 2048383 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_3074133733 proquest_journals_3166952369 pubmed_primary_38945856 crossref_primary_10_7883_yoken_JJID_2024_184 crossref_citationtrail_10_7883_yoken_JJID_2024_184 jstage_primary_article_yoken_77_6_77_JJID_2024_184_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024/11/29 |
PublicationDateYYYYMMDD | 2024-11-29 |
PublicationDate_xml | – month: 11 year: 2024 text: 2024/11/29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Japanese Journal of Infectious Diseases |
PublicationTitleAlternate | Jpn J Infect Dis |
PublicationYear | 2024 |
Publisher | National Institute of Infectious Diseases Japan Science and Technology Agency |
Publisher_xml | – sequence: 0 name: National Institute of Infectious Diseases – name: Japan Science and Technology Agency |
References | 12. Lee MY, Upadhyay AA, Walum H, et al. Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infection. PLoS Pathog. 2021;17:e1009674. 28. COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023;621:E7-E26. 1. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol. 2012;24:501-506. 23. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at <https://www.R-project.org/>, 2021. Accessed July 23, 2024. 32. Hearps AC, Maisa A, Cheng WJ, et al. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012;26:843-853. 6. Favara G, Barchitta M, Maugeri A, et al. HIV infection does not affect the risk of death of COVID-19 patients: a systematic review and meta-analysis of epidemiological studies. J Glob Health. 2022;12:05036. 39. Noel N, Boufassa F, Lécuroux C, et al. Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients. AIDS. 2014;28:467-476. 34. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol. 2002;168:3660-3666. 40. Semulimi AW, Batte C, Bayiyana A, et al. Serum E-selectin and endothelial cell-specific molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study. AIDS Res Ther. 2023;20:26. 13. Hove-Skovsgaard M, Moller DL, Hald A, et al. Improved induced innate immune response after cART initiation in people with HIV. Front Immunol. 2022;13:974767. 27. Hsu RJ, Yu WC, Peng GR, et al. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Front Immunol. 2022;13:832394. 29. Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. 8. Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636-1643. 19. Khan K, Lustig G, Bernstein M, et al. Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26.CoV2.S vaccination in people living with human immunodeficiency virus (HIV). Clin Infect Dis. 2022;75:e857-e864. 30. Tilton JC, Manion MM, Luskin MR, et al. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol. 2008;82:3997-4006. 26. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75. 2. Yang X, Sun J, Patel RC, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021;8:e690-e700. 33. Akiyama H, Gummuluru S. HIV-1 persistence and chronic induction of innate immune responses in macrophages. Viruses. 2020;12:711. 7. Moller IK, Gisslen M, Wagner P, et al. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study. HIV Med. 2023;24:1045-1055. 11. Coindre S, Tchitchek N, Alaoui L, et al. Mass cytometry analysis reveals complex cell-state modifications of blood myeloid cells during HIV infection. Front Immunol. 2019;10:2677. 3. Kassanjee R, Davies MA, Ngwenya O, et al. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa. J Int AIDS Soc. 2023;26:e26104. 10. Centlivre M, Legrand N, Steingrover R, et al. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J Leukoc Biol. 2011;89:785-795. 36. Nakayama K, Nakamura H, Koga M, et al. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Res Hum Retroviruses. 2012;28:702-714. 14. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711-2720. 18. Hwa SH, Snyman J, Bernstein M, et al. Association between human immunodeficiency virus viremia and compromised neutralization of severe acute respiratory syndrome coronavirus 2 beta variant. J Infect Dis. 2023;227:211-220. 37. Valencia I, Lumpuy-Castillo J, Magalhaes G, et al. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. Cardiovasc Diabetol. 2024;23:75. 22. Wei T, Simko V. R package 'corrplot': visualization of a correlation matrix (Version 0.92). Available at <https://github.com/taiyun/corrplot>, 2021. Accessed July 23, 2024. 25. Sebastien Le JJ, Francois Husson. FactoMineR: an R package for multivariate analysis. J Statistical Software. 2008;25:1-18. 31. Mangino G, Percario ZA, Fiorucci G, et al. HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS One. 2011;6:e22982. 4. Wit FWNM, Reiss P, Rijnders B, et al. COVID-19 in people with HIV in the Netherlands. AIDS. 2023;37:1671-1681. 16. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350-354. 21. Donadeu L, Tiraboschi JM, Scevola S, et al. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV. AIDS. 2022;36:1373-1382. 24. Kassambara A, Mundt f. Factoextra: extract and visualize the results of multivariate data analyses. R package version 1.0.7, Available at <https://CRAN.R-project.org/package=factoextra>, 2020. Accessed July 23, 2024. 20. Alrubayyi A, Gea-Mallorqui E, Touizer E, et al. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV. Nat Commun. 2021;12:5839. 17. Nkosi T, Chasara C, Papadopoulos AO, et al. Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition. Elife. 2022;11:e78374. 38. Guha D, Misra V, Yin J, et al. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023;37:2137-2147. 5. Patel VV, Felsen UR, Fisher M, et al. Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2021;86:224-230. 15. Migueles SA, Weeks KA, Nou E, et al. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol. 2009;83:11876-11889. 35. Shankar P, Russo M, Harnisch B, et al. Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection. Blood. 2000;96:3094-3101. 9. Nakayama R, Bunya N, Tagami T, et al. Associated organs and system with COVID-19 death with information of organ support: a multicenter observational study. BMC Infect Dis. 2023;23:814. 22 23 24 25 26 27 28 29 30 31 10 32 11 33 12 34 13 35 14 36 15 37 16 38 17 39 18 19 1 2 3 4 5 6 7 8 9 40 20 21 |
References_xml | – reference: 37. Valencia I, Lumpuy-Castillo J, Magalhaes G, et al. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. Cardiovasc Diabetol. 2024;23:75. – reference: 19. Khan K, Lustig G, Bernstein M, et al. Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26.CoV2.S vaccination in people living with human immunodeficiency virus (HIV). Clin Infect Dis. 2022;75:e857-e864. – reference: 25. Sebastien Le JJ, Francois Husson. FactoMineR: an R package for multivariate analysis. J Statistical Software. 2008;25:1-18. – reference: 24. Kassambara A, Mundt f. Factoextra: extract and visualize the results of multivariate data analyses. R package version 1.0.7, Available at <https://CRAN.R-project.org/package=factoextra>, 2020. Accessed July 23, 2024. – reference: 29. Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:eabd4585. – reference: 12. Lee MY, Upadhyay AA, Walum H, et al. Tissue-specific transcriptional profiling of plasmacytoid dendritic cells reveals a hyperactivated state in chronic SIV infection. PLoS Pathog. 2021;17:e1009674. – reference: 26. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75. – reference: 5. Patel VV, Felsen UR, Fisher M, et al. Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2021;86:224-230. – reference: 20. Alrubayyi A, Gea-Mallorqui E, Touizer E, et al. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV. Nat Commun. 2021;12:5839. – reference: 28. COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023;621:E7-E26. – reference: 4. Wit FWNM, Reiss P, Rijnders B, et al. COVID-19 in people with HIV in the Netherlands. AIDS. 2023;37:1671-1681. – reference: 36. Nakayama K, Nakamura H, Koga M, et al. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection. AIDS Res Hum Retroviruses. 2012;28:702-714. – reference: 18. Hwa SH, Snyman J, Bernstein M, et al. Association between human immunodeficiency virus viremia and compromised neutralization of severe acute respiratory syndrome coronavirus 2 beta variant. J Infect Dis. 2023;227:211-220. – reference: 40. Semulimi AW, Batte C, Bayiyana A, et al. Serum E-selectin and endothelial cell-specific molecule-1 levels among people living with HIV on long term ART in Uganda: a pilot cross-sectional study. AIDS Res Ther. 2023;20:26. – reference: 11. Coindre S, Tchitchek N, Alaoui L, et al. Mass cytometry analysis reveals complex cell-state modifications of blood myeloid cells during HIV infection. Front Immunol. 2019;10:2677. – reference: 23. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at <https://www.R-project.org/>, 2021. Accessed July 23, 2024. – reference: 27. Hsu RJ, Yu WC, Peng GR, et al. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Front Immunol. 2022;13:832394. – reference: 15. Migueles SA, Weeks KA, Nou E, et al. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol. 2009;83:11876-11889. – reference: 35. Shankar P, Russo M, Harnisch B, et al. Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection. Blood. 2000;96:3094-3101. – reference: 30. Tilton JC, Manion MM, Luskin MR, et al. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro. J Virol. 2008;82:3997-4006. – reference: 17. Nkosi T, Chasara C, Papadopoulos AO, et al. Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition. Elife. 2022;11:e78374. – reference: 33. Akiyama H, Gummuluru S. HIV-1 persistence and chronic induction of innate immune responses in macrophages. Viruses. 2020;12:711. – reference: 22. Wei T, Simko V. R package 'corrplot': visualization of a correlation matrix (Version 0.92). Available at <https://github.com/taiyun/corrplot>, 2021. Accessed July 23, 2024. – reference: 16. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350-354. – reference: 39. Noel N, Boufassa F, Lécuroux C, et al. Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients. AIDS. 2014;28:467-476. – reference: 6. Favara G, Barchitta M, Maugeri A, et al. HIV infection does not affect the risk of death of COVID-19 patients: a systematic review and meta-analysis of epidemiological studies. J Glob Health. 2022;12:05036. – reference: 7. Moller IK, Gisslen M, Wagner P, et al. COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study. HIV Med. 2023;24:1045-1055. – reference: 9. Nakayama R, Bunya N, Tagami T, et al. Associated organs and system with COVID-19 death with information of organ support: a multicenter observational study. BMC Infect Dis. 2023;23:814. – reference: 10. Centlivre M, Legrand N, Steingrover R, et al. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J Leukoc Biol. 2011;89:785-795. – reference: 34. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol. 2002;168:3660-3666. – reference: 21. Donadeu L, Tiraboschi JM, Scevola S, et al. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV. AIDS. 2022;36:1373-1382. – reference: 31. Mangino G, Percario ZA, Fiorucci G, et al. HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS One. 2011;6:e22982. – reference: 8. Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636-1643. – reference: 38. Guha D, Misra V, Yin J, et al. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy. AIDS. 2023;37:2137-2147. – reference: 13. Hove-Skovsgaard M, Moller DL, Hald A, et al. Improved induced innate immune response after cART initiation in people with HIV. Front Immunol. 2022;13:974767. – reference: 2. Yang X, Sun J, Patel RC, et al. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021;8:e690-e700. – reference: 3. Kassanjee R, Davies MA, Ngwenya O, et al. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa. J Int AIDS Soc. 2023;26:e26104. – reference: 14. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711-2720. – reference: 1. Deeks SG, Verdin E, McCune JM. Immunosenescence and HIV. Curr Opin Immunol. 2012;24:501-506. – reference: 32. Hearps AC, Maisa A, Cheng WJ, et al. HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS. 2012;26:843-853. – ident: 36 doi: 10.1089/aid.2011.0073 – ident: 12 doi: 10.1371/journal.ppat.1009674 – ident: 34 doi: 10.4049/jimmunol.168.7.3660 – ident: 40 doi: 10.1186/s12981-023-00519-x – ident: 7 doi: 10.1111/hiv.13515 – ident: 19 doi: 10.1093/cid/ciab1008 – ident: 4 doi: 10.1097/QAD.0000000000003597 – ident: 5 doi: 10.1097/QAI.0000000000002578 – ident: 8 doi: 10.1038/s41591-020-1051-9 – ident: 1 doi: 10.1016/j.coi.2012.05.004 – ident: 26 doi: 10.1016/j.cytogfr.2020.06.001 – ident: 28 – ident: 20 doi: 10.1038/s41467-021-26137-7 – ident: 24 – ident: 13 doi: 10.3389/fimmu.2022.974767 – ident: 14 doi: 10.1182/blood-2002-07-2103 – ident: 10 doi: 10.1189/jlb.0410231 – ident: 16 doi: 10.1038/nature05115 – ident: 22 – ident: 6 doi: 10.7189/jogh.12.05036 – ident: 30 doi: 10.1128/JVI.01545-07 – ident: 18 doi: 10.1093/infdis/jiac343 – ident: 21 doi: 10.1097/QAD.0000000000003276 – ident: 35 doi: 10.1182/blood.V96.9.3094.h8003094_3094_3101 – ident: 27 doi: 10.3389/fimmu.2022.832394 – ident: 33 doi: 10.3390/v12070711 – ident: 11 doi: 10.3389/fimmu.2019.02677 – ident: 39 doi: 10.1097/QAD.0000000000000174 – ident: 38 doi: 10.1101/2023.07.23.23293053 – ident: 31 doi: 10.1371/journal.pone.0022982 – ident: 17 doi: 10.7554/eLife.78374 – ident: 15 doi: 10.1128/JVI.01153-09 – ident: 29 – ident: 25 doi: 10.18637/jss.v025.i01 – ident: 32 doi: 10.1097/QAD.0b013e328351f756 – ident: 37 doi: 10.1186/s12933-023-02097-8 – ident: 2 doi: 10.1016/S2352-3018(21)00239-3 – ident: 3 doi: 10.1002/jia2.26104 – ident: 9 doi: 10.1186/s12879-023-08817-5 – ident: 23 |
SSID | ssj0025510 |
Score | 2.3682084 |
Snippet | Persistent inflammation during chronic human immunodeficiency virus (HIV) infection may affect the immune response against severe acute respiratory... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 301 |
SubjectTerms | Adult Aged Antiretroviral agents Antiretroviral therapy Chronic infection Coronaviruses COVID-19 COVID-19 - blood COVID-19 - immunology Cytokines Cytokines - blood Female HIV HIV Infections - blood HIV Infections - complications HIV Infections - immunology Human immunodeficiency virus Humans Immune response Immune system Infections Inflammation Inflammation - blood innate responses Intercellular adhesion molecule 1 IP-10 protein Lipopolysaccharides Male Middle Aged Plasma levels proinflammatory cytokines Respiratory diseases SARS-CoV-2 SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Tumor necrosis factor-α Viral diseases α-Interferon |
Title | Characterization of the Proinflammatory Cytokine Profile during Acute SARS-CoV-2 Infection in People with Human Immunodeficiency Virus |
URI | https://www.jstage.jst.go.jp/article/yoken/77/6/77_JJID.2024.184/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/38945856 https://www.proquest.com/docview/3166952369 https://www.proquest.com/docview/3074133733 |
Volume | 77 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of Infectious Diseases, 2024/11/29, Vol.77(6), pp.301-310 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKQIgXxH8KAxmJt5HSxo7jPpayqau2UW3Z1LfISZytlCWobYTaD8AH45NxthOnrcYEPDSqUsex-vv5fHe-OyP0PkkYZ1GaOjH1hENj7jlRLNoOKMMurC6Sd3TI__EJG5zT4dgbNxq_1qKWikXUilc35pX8D6pwD3BVWbL_gKztFG7Ad8AXroAwXP8K476ttryymp9SJEezHLoHrK_NHnp_ucinSp0cmRO6q-TEXqyiBM56p2dOP79wXJAWJjRLhz-OdHC58dQaX_-hSibJE6mqTuiUzYvJrHQcVPotrL3qTMvNihSm02JebQdZPb6XrYqZ8WH3wB5YSRvvcVrAYvhDGn_rURFPres_uJrsBVcFfESuSHtp_dliKpbiWjiDfJ4vy1S3fDZZd2y4VGX4ubX41AO2Ek7tItSbDXs9nZi6JrcJpQ4j5iTjljT3OKcOaE9sXdiXZ8ZMasm9vYb4nKtaFst8KrPWcHj4uaUG1-pwWi-ZVZjAyZfw4PzoKAz2x8EddNcFU0UnnI9tmBFYbKYiRjVAU_lKveTjDa_Y0I7ufQUD4VL-2fbROlDwCD0sjRfcM0x8jBoye4LuH5fhGU_Rz21C4jzFQEi8RUhcERKXhMSGkFgTEteExJaQeJJhQ0isCIk1IfE2IbEm5DMUHOwH_YFTHvQBEsL1qJMQ6QkhZVumKZgXXtqOKJjhoL7BgsMoj4gUPu9I6tNYuKKbkC7vxB5JolTKyCXP0U6WZ_IlwkkaccGI9NWOPmMiYj6oY4Jzxn3iyaSJ3Or_DeOyCL46i-VbCMawAiXUoIQKlFCBEgIoTfTBPvTd1IC5vfknA5xtXAqIsrHvh0xdNh6ybVSyJci2JtqtQA_LGTsPSYexrucS1m2id_ZnWA_UJh_MbpjIIVE2AiE-IU30wpDFjgOME-pxj726vfPX6EE9H3fRzmJWyDegei-it5rbvwEAF-Ne |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+the+Proinflammatory+Cytokine+Profile+during+Acute+SARS-CoV-2+Infection+in+People+with+Human+Immunodeficiency+Virus&rft.jtitle=Japanese+journal+of+infectious+diseases&rft.au=Anzurez%2C+Alitzel&rft.au=Runtuwene%2C+Lucky&rft.au=Thi+Thu+Thao+Dang&rft.au=Nakayama-Hosoya%2C+Kaori&rft.date=2024-11-29&rft.pub=Japan+Science+and+Technology+Agency&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=77&rft.issue=6&rft_id=info:doi/10.7883%2Fyoken.JJID.2024.184&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon |